What is HeartFlow?
HeartFlow operates at the intersection of human ingenuity and advanced computational technology, providing clinicians with non-invasive, actionable insights into coronary artery disease. By transforming how heart conditions are diagnosed and managed, the company has established a unique market position that bridges the gap between traditional imaging and interventional cardiology. Its platform is designed to reduce unnecessary procedures while improving patient outcomes, making it a critical asset in the modern healthcare ecosystem. The company's trajectory from early-stage development to its current enterprise-level maturity reflects its success in navigating complex regulatory and clinical landscapes.
How much funding has HeartFlow raised?
HeartFlow has raised a total of $890.7M across 11 funding rounds:
Series C
$104.7M
Unspecified
$35.9M
Series D
$99.9M
Series E
$240M
Unspecified
$65M
Series F
$215M
Other Financing Round
$98M
Series C (2014): $104.7M backed by Orkila Capital, LLC, U.S. Venture Partners, HealthCor Partners Management, Sandbox Industries Inc., and Capricorn Investment Group, LLC
Unspecified (2015): $35.9M with participation from Capricorn Investment Group and U.S. Venture Partners
Series D (2016): $99.9M led by Panorama Point Partners
Series E (2018): $240M supported by Wellington Management, Baillie Gifford, U.S. Venture Partners, Rancilio Cube srl, Blue Cross Blue Shield, and GE Ventures
Unspecified (2019): $65M, investors not publicly disclosed
Series F (2023): $215M backed by Capricorn Investment Group, Wellington Management, Baillie Gifford, Hayfin, Janus Henderson Investors, HealthCor Partners Management, Martis Capital, Bain Capital Life Sciences, and USVP Management
Other Financing Round (2025): $98M with participation from Martis Capital, HealthCor Partners Management, Bain Capital, Hayfin, Capricorn Group, US Venture Partners, and Fidelity
Key Investors in HeartFlow
U.S. Venture Partners
A prominent Silicon Valley venture capital firm specializing in early-stage investments across cybersecurity, enterprise software, and healthcare sectors.
Wellington Management
A global, independent investment management firm providing institutional clients with tailored solutions across equities, fixed income, and alternative strategies.
Capricorn Investment Group
A Palo Alto-based investment firm managing diversified portfolios with a strong focus on sustainable, climate, and impact-oriented investments.
What's next for HeartFlow?
With the infusion of this latest capital, HeartFlow is well-positioned to accelerate its innovation pipeline and expand its global footprint. The strategic focus will likely center on deepening its clinical evidence base, enhancing its software-as-a-service (SaaS) diagnostic capabilities, and forging new partnerships with major healthcare providers. As the company moves beyond its current lifecycle stage, the emphasis will shift toward operational efficiency and market penetration, ensuring that its precision heart care technology becomes the standard of care for patients worldwide. The continued support from institutional heavyweights suggests a long-term commitment to maintaining HeartFlow's competitive edge in the rapidly evolving digital health market.
See full HeartFlow company page
